Vigilant Capital Management LLC cut its stake in CVS Health Corp (NYSE:CVS) by 57.8% in the fourth quarter, Holdings Channel reports. The fund owned 56,338 shares of the pharmacy operator’s stock after selling 77,086 shares during the quarter. Vigilant Capital Management LLC’s holdings in CVS Health were worth $4,085,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently made changes to their positions in the company. Fieldpoint Private Securities LLC lifted its position in CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 1,000 shares during the last quarter. Wealthcare Advisory Partners LLC lifted its position in CVS Health by 330.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 991 shares during the last quarter. Arcadia Investment Management Corp MI lifted its position in CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after acquiring an additional 726 shares during the last quarter. MPS Loria Financial Planners LLC purchased a new stake in CVS Health in the second quarter valued at $119,000. Finally, Cerebellum GP LLC acquired a new position in CVS Health in the fourth quarter valued at $130,000. 84.12% of the stock is owned by hedge funds and other institutional investors.
In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the sale, the executive vice president now owns 15,556 shares of the company’s stock, valued at $1,166,700. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Helena Foulkes sold 19,965 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the completion of the sale, the executive vice president now directly owns 65,072 shares in the company, valued at approximately $4,622,714.88. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by insiders.
Shares of CVS Health Corp (CVS) opened at $69.27 on Monday. The company has a market cap of $70,280.00, a PE ratio of 10.71, a P/E/G ratio of 1.15 and a beta of 1.03. CVS Health Corp has a fifty-two week low of $66.45 and a fifty-two week high of $84.00. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59.
CVS Health (NYSE:CVS) last released its quarterly earnings data on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.88 by $0.04. The firm had revenue of $48.39 billion for the quarter, compared to the consensus estimate of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.71 earnings per share. analysts forecast that CVS Health Corp will post 6.37 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Vigilant Capital Management LLC Trims Position in CVS Health Corp (CVS)” was reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.themarketsdaily.com/2018/03/12/vigilant-capital-management-llc-trims-position-in-cvs-health-corp-cvs.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.